Abstract
Summary
The above data demonstrate an exceptionally interesting and unusual case, namely, a specific inhibitor of AcG (labile factor), occurring in a human subject. Its presence satisfactorily explains the anomalies of a number of clotting tests and accounts for the clinical hemorrhagic syndrome.
Get full access to this article
View all access options for this article.